首页|补中益气汤加减治疗慢性肾炎蛋白尿的临床效果观察

补中益气汤加减治疗慢性肾炎蛋白尿的临床效果观察

扫码查看
目的 探讨补中益气汤加减治疗慢性肾炎蛋白尿的临床效果。方法 将 82 例慢性肾炎蛋白尿患者随机分为对照组及观察组,每组 41 例。对照组使用常规西医治疗,观察组在对照组基础上使用补中益气汤加减治疗。对比两组的临床疗效、肾功能指标[血肌酐(Scr)、尿素氮(BUN)]及蛋白尿指标(24 h尿蛋白定量、24 h尿微量白蛋白)水平、中医证候积分、炎性因子[白细胞介素-6(IL-6)、白细胞介素-17(IL-17)、肿瘤坏死因子-α(TNF-α)、C反应蛋白(CRP)]水平。结果 观察组治疗总有效率为 95。12%,明显高于对照组的 73。17%(P<0。05)。观察组治疗后Scr、BUN、24 h尿蛋白定量、24 h尿微量白蛋白分别为(77。01±21。62)μmol/L、(4。23±1。06)mmol/L、(25。76±3。84)mg/L、(25。43±3。18)mg/L,均低于对照组的(90。47±25。84)μmol/L、(7。17±1。28)mmol/L、(29。64±4。03)mg/L、(31。06±3。49)mg/L(P<0。05)。观察组治疗后肢体浮肿、倦怠乏力、便溏、胃脘胀满中医证候积分分别为(0。98±0。21)、(0。90±0。18)、(0。92±0。19)、(0。89±0。16)分,明显低于对照组的(1。65±0。24)、(1。59±0。22)、(1。64±0。23)、(1。58±0。21)分(P<0。05)。观察组治疗后CRP、IL-6、IL-17、TNF-α水平分别为(16。03±5。78)mg/L、(15。03±3。37)ng/L、(26。89±6。28)ng/L、(37。93±4。76)μg/L,均低于对照组的(25。93±7。33)mg/L、(19。71±3。86)ng/L、(53。49±9。82)ng/L、(46。38±5。14)μg/L(P<0。05)。结论 补中益气汤加减治疗慢性肾炎蛋白尿的临床效果显著,能有效降低尿蛋白水平,改善肾功能,减轻炎症反应,缓解证候。
Clinical observation of modified Buzhong Yiqi Decoction in treating chronic nephritis proteinuria
Objective To explore the clinical effect of modified Buzhong Yiqi Decoction in treating chronic nephritis proteinuria.Methods 82 patients with chronic nephritis proteinuria were randomly divided into a control group and an observation group,with 41 cases in each group.The control group was treated with conventional Western medicine,and the observation group was treated with modified Buzhong Yiqi Decoction on the basis of the control group.Both groups were compared in terms of clinical efficacy,renal function indexes[serum creatinine(Scr),blood urea nitrogen(BUN)]and proteinuria indexes(24 h urinary protein quantity,24 h urinary microalbumin)level,traditional Chinese medicine syndrome score,inflammatory factors[interleukin-6(IL-6),interleukin-17(IL-17),tumor necrosis factor-α(TNF-α),C-reactive protein(CRP)]level.Results The total effective rate of the observation group was 95.12%,which was significantly higher than 73.17%of the control group(P<0.05).After treatment,Scr,BUN,24 h urinary protein quantity and 24 h urinary microalbumin in the observation group were(77.01±21.62)μmol/L,(4.23±1.06)mmol/L,(25.76±3.84)mg/L and(25.43±3.18)mg/L,which were lower than(90.47±25.84)μmol/L,(7.17±1.28)mmol/L,(29.64±4.03)mg/L and(31.06±3.49)mg/L in the control group(P<0.05).After treatment,the traditional Chinese medicine syndrome scores of edema,fatigue,loose stool and gastric distention in the observation group were(0.98±0.21),(0.90±0.18),(0.92±0.19)and(0.89±0.16)points,which were significantly lower than(1.65±0.24),(1.59±0.22),(1.64±0.23)and(1.58±0.21)points in the control group(P<0.05).After treatment,the levels of CRP,IL-6,IL-17 and TNF-α in the observation group were(16.03±5.78)mg/L,(15.03±3.37)ng/L,(26.89±6.28)ng/L and(37.93±4.76)μg/L,which were lower than(25.93±7.33)mg/L,(19.71±3.86)ng/L,(53.49±9.82)ng/L and(46.38±5.14)μg/L in the control group(P<0.05).Conclusion Modified Buzhong Yiqi Decoction has a significant clinical effect in treating chronic nephritis proteinuria,which can effectively reduce urinary protein level,improve renal function,alleviate inflammatory reaction and relieve syndromes.

Chronic nephritisProteinuriaBuzhong Yiqi DecoctionModifiedClinical effect

翁晓婷

展开 >

363401 东山县医院肾内科

慢性肾炎 蛋白尿 补中益气汤 加减 临床效果

2024

中国现代药物应用
中国水利电力医学科学技术学会

中国现代药物应用

影响因子:0.862
ISSN:1673-9523
年,卷(期):2024.18(9)